V. Manax

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Adaptive platform trials: definition, design, conduct and reporting considerations

Herman Goossens, Donald A. Berry, Lorenzo Trippa, 2019, Nature Reviews Drug Discovery.

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

M. Reni, J. Tabernero, D. V. Von Hoff, 2016, British Journal of Cancer.

Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) ± gemcitabine (Gem) in solid tumors: Interim results from the pancreatic cancer (PC) cohorts.

E. Kwak, Z. Wainberg, P. O'dwyer, 2017 .

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

M. Reni, J. Tabernero, D. V. Von Hoff, 2016, British Journal of Cancer.